Free tool
Healthcare stocks
We cover 691 companies in the Healthcare sector. The median market value in the group is $1.03B. Across the group, the median move over the past trading day is −0.25%. 64% of the 672 with a 200-day average trade above it. Price change over the past year runs from −36.4% to +179.1% across the middle 80 percent of the group, with a median of +16.0%. Across the group, 8 companies currently carry a tier A volume signal.
Other lists in this group
Table
691 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% | Nov 5, 2026 |
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% | Oct 28, 2026 |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% | Nov 5, 2026 |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% | Nov 9, 2026 |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% | Nov 16, 2026 |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% | Nov 12, 2026 |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% | Nov 3, 2026 |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% | Nov 9, 2026 |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% | Nov 4, 2026 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% | Nov 5, 2026 |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% | Nov 4, 2026 |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% | Aug 27, 2026 |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% | Nov 3, 2026 |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% | Oct 29, 2026 |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +4.01% | Nov 2, 2026 |
| 4523.T | Eisai Co., Ltd. | $8.48B | Mid cap | +7.64% | Nov 10, 2026 |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% | Nov 2, 2026 |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% | Nov 5, 2026 |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% | Aug 27, 2026 |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% | Oct 28, 2026 |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% | Nov 3, 2026 |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% | Nov 3, 2026 |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% | Nov 4, 2026 |
| 2413.T | M3, Inc. | $7.53B | Mid cap | −17.22% | Nov 11, 2026 |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% | Oct 29, 2026 |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% | Nov 12, 2026 |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% | Nov 4, 2026 |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% | Nov 17, 2026 |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% | Nov 3, 2026 |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% | Oct 27, 2026 |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% | Nov 9, 2026 |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% | Oct 21, 2026 |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% | Nov 9, 2026 |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% | Nov 9, 2026 |
| 3391.T | Tsuruha Holdings Inc. | $6.89B | Mid cap | +5.97% | Oct 9, 2026 |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.82B | Mid cap | +15.35% | Oct 23, 2026 |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% | Nov 11, 2026 |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +53.99% | Nov 13, 2026 |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% | Nov 5, 2026 |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% | Nov 11, 2026 |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% | Nov 3, 2026 |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% | Nov 11, 2026 |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.74% | Nov 12, 2026 |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% | Nov 11, 2026 |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +196.85% | Nov 3, 2026 |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% | Nov 9, 2026 |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% | Nov 3, 2026 |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% | Oct 29, 2026 |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% | Oct 29, 2026 |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% | Nov 2, 2026 |
| BLCO.TO | Bausch + Lomb Corporation | $6.18B | Mid cap | +19.34% | Oct 28, 2026 |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% | Oct 28, 2026 |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% | Nov 5, 2026 |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% | Nov 5, 2026 |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.07B | Mid cap | +46.02% | Nov 5, 2026 |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% | Oct 27, 2026 |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% | Nov 5, 2026 |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% | Nov 4, 2026 |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% | Nov 5, 2026 |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% | Oct 29, 2026 |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% | Nov 5, 2026 |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% | Nov 9, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% | Nov 3, 2026 |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% | Sep 1, 2026 |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% | Oct 29, 2026 |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% | Nov 4, 2026 |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% | Nov 5, 2026 |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.89B | Mid cap | −11.24% | Nov 5, 2026 |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% | Nov 5, 2026 |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% | Nov 5, 2026 |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% | Nov 5, 2026 |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +90.31% | Nov 11, 2026 |
| WAY | Waystar Holding Corp. | $4.63B | Mid cap | −34.97% | Oct 28, 2026 |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.63B | Mid cap | +66.34% | Oct 29, 2026 |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% | Nov 5, 2026 |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% | Nov 5, 2026 |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% | Oct 28, 2026 |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% | Nov 11, 2026 |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% | Nov 5, 2026 |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% | Nov 5, 2026 |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% | Nov 4, 2026 |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% | Nov 12, 2026 |
| MANE | Veradermics, Incorporated | $4.29B | Mid cap | +172.32% | Nov 12, 2026 |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% | Nov 4, 2026 |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% | Nov 5, 2026 |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% | Nov 11, 2026 |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% | Oct 29, 2026 |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% | Nov 5, 2026 |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% | Nov 4, 2026 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% | Nov 5, 2026 |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −29.83% | Nov 5, 2026 |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.05B | Mid cap | −3.59% | Oct 30, 2026 |
| LEGN | Legend Biotech Corporation | $4.02B | Mid cap | −40.44% | Nov 11, 2026 |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% | Nov 9, 2026 |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% | Oct 28, 2026 |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% | Nov 5, 2026 |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% | Nov 5, 2026 |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% | Oct 27, 2026 |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% | Oct 23, 2026 |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% | Nov 4, 2026 |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% | Nov 5, 2026 |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% | Aug 27, 2026 |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.74B | Mid cap | +21.45% | Nov 5, 2026 |
| 7459.T | MediPal Holdings Corporation | $3.72B | Mid cap | +13.38% | Nov 5, 2026 |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% | Nov 5, 2026 |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% | Nov 9, 2026 |
| OPCH | Option Care Health, Inc. | $3.60B | Mid cap | −15.91% | Oct 29, 2026 |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% | Nov 3, 2026 |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% | Nov 5, 2026 |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% | Nov 11, 2026 |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% | Nov 9, 2026 |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% | Nov 6, 2026 |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% | Nov 5, 2026 |
| 22Z.DE | Zealand Pharma A/S | $3.37B | Mid cap | −28.16% | Nov 12, 2026 |
| ZEAL.CO | Zealand Pharma A/S | $3.34B | Mid cap | −25.94% | Nov 12, 2026 |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% | Nov 5, 2026 |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% | Nov 5, 2026 |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% | Nov 4, 2026 |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.26B | Mid cap | −26.59% | Oct 13, 2026 |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% | Sep 17, 2026 |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% | Nov 5, 2026 |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% | Nov 3, 2026 |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% | Oct 29, 2026 |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% | Nov 9, 2026 |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% | Nov 5, 2026 |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% | Nov 5, 2026 |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.13B | Mid cap | −28.60% | Oct 8, 2026 |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +60.64% | Oct 27, 2026 |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% | Nov 4, 2026 |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% | Nov 12, 2026 |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% | Nov 4, 2026 |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% | Oct 27, 2026 |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% | Nov 5, 2026 |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% | Nov 5, 2026 |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +55.61% | Nov 5, 2026 |
| ALHC | Alignment Healthcare, Inc. | $2.88B | Mid cap | −13.88% | Oct 29, 2026 |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% | Nov 4, 2026 |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% | Nov 12, 2026 |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% | Nov 11, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% | Oct 8, 2026 |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.34% | Nov 13, 2026 |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% | Nov 5, 2026 |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% | Nov 12, 2026 |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% | Oct 28, 2026 |
| PRVA | Privia Health Group, Inc. | $2.71B | Mid cap | −3.13% | Nov 5, 2026 |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% | Oct 27, 2026 |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% | Oct 28, 2026 |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% | Nov 5, 2026 |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% | Nov 12, 2026 |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% | Nov 3, 2026 |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% | Nov 3, 2026 |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% | Nov 3, 2026 |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% | Nov 12, 2026 |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% | Nov 9, 2026 |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% | Nov 12, 2026 |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% | Nov 13, 2026 |
| EMEIS.PA | emeis Société anonyme | $2.55B | Mid cap | +10.93% | Sep 23, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% | Oct 8, 2026 |
| 2784.T | Alfresa Holdings Corporation | $2.53B | Mid cap | +6.80% | Nov 9, 2026 |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% | Nov 5, 2026 |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% | Nov 12, 2026 |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% | Nov 2, 2026 |
| CURA.TO | Curaleaf Holdings, Inc. | $2.51B | Mid cap | +197.74% | Nov 4, 2026 |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% | Nov 13, 2026 |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% | Nov 12, 2026 |
| PBH | Prestige Consumer Healthcare Inc. | $2.47B | Mid cap | −22.12% | Nov 5, 2026 |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% | Oct 29, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% | Nov 2, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% | Oct 1, 2026 |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% | Oct 28, 2026 |
| BHC.TO | Bausch Health Companies Inc. | $2.43B | Mid cap | −9.88% | Oct 28, 2026 |
| KLRA | Kailera Therapeutics, Inc. | $2.39B | Mid cap | −29.08% | Oct 29, 2026 |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% | Nov 4, 2026 |
| ALMR | Alamar Biosciences, Inc. | $2.36B | Mid cap | +54.91% | Nov 5, 2026 |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% | Nov 9, 2026 |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% | Nov 2, 2026 |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% | Nov 12, 2026 |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% | Nov 3, 2026 |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% | Oct 30, 2026 |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.30B | Mid cap | +44.68% | Nov 16, 2026 |
| MLYS | Mineralys Therapeutics, Inc. | $2.28B | Mid cap | +70.22% | Nov 10, 2026 |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% | Oct 27, 2026 |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% | Sep 29, 2026 |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% | Nov 4, 2026 |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +1.03% | Aug 27, 2026 |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% | Nov 2, 2026 |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% | Nov 5, 2026 |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% | Aug 27, 2026 |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% | Nov 11, 2026 |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% | Nov 9, 2026 |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% | Aug 27, 2026 |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% | Nov 2, 2026 |
| 302440.KS | SK bioscience Co.,Ltd. | $2.18B | Mid cap | −20.29% | Oct 26, 2026 |
| XRAY | DENTSPLY SIRONA Inc. | $2.18B | Mid cap | −21.61% | Nov 5, 2026 |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +146.56% | Nov 11, 2026 |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% | Nov 5, 2026 |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −12.93% | Nov 12, 2026 |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% | Nov 4, 2026 |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% | Nov 12, 2026 |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +70.71% | Nov 4, 2026 |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% | Nov 3, 2026 |
| GN.CO | GN Store Nord A/S | $2.13B | Mid cap | −18.50% | Nov 5, 2026 |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% | Nov 4, 2026 |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% | Nov 5, 2026 |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% | Oct 29, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% | Sep 10, 2026 |
| GENB | Generate Biomedicines, Inc. | $2.07B | Mid cap | +27.59% | Nov 5, 2026 |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +7.69% | Nov 4, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% | Sep 29, 2026 |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% | Nov 4, 2026 |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% | Oct 29, 2026 |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% | Nov 3, 2026 |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% | Oct 29, 2026 |
| GHRS | GH Research PLC | $1.99B | Small cap | +112.84% | Nov 5, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% | Oct 22, 2026 |
| PIII | P3 Health Partners Inc. | $1.98B | Small cap | +26.37% | Nov 12, 2026 |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% | Nov 5, 2026 |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% | Nov 5, 2026 |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% | Nov 4, 2026 |
| EMBLA.CO | Embla Medical hf. | $1.93B | Small cap | −6.94% | Oct 20, 2026 |
| GXE.DE | Lakefront Biotherapeutics NV | $1.93B | Small cap | −44.50% | Nov 12, 2026 |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% | Nov 5, 2026 |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% | Nov 5, 2026 |
| LKFT | Lakefront Biotherapeutics NV | $1.91B | Small cap | −11.39% | Nov 12, 2026 |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% | Nov 9, 2026 |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% | Nov 5, 2026 |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% | Nov 5, 2026 |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% | Nov 9, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% | Nov 4, 2026 |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% | Nov 4, 2026 |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% | Nov 9, 2026 |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% | Nov 3, 2026 |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% | Nov 5, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% | Nov 13, 2026 |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% | Nov 5, 2026 |
| 4540.T | Tsumura & Co. | $1.79B | Small cap | +10.98% | Nov 9, 2026 |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% | Nov 12, 2026 |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% | Nov 2, 2026 |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% | Nov 6, 2026 |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% | Nov 2, 2026 |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% | Nov 5, 2026 |
| ALVO | Alvotech | $1.75B | Small cap | −38.85% | Nov 11, 2026 |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% | Nov 6, 2026 |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% | Nov 5, 2026 |
| SIA.TO | Sienna Senior Living Inc. | $1.65B | Small cap | +25.96% | Nov 12, 2026 |
| 7716.T | Nakanishi Inc. | $1.65B | Small cap | +52.27% | Nov 5, 2026 |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% | Nov 16, 2026 |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% | Nov 10, 2026 |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% | Nov 9, 2026 |
| 8129.T | Toho Holdings Co., Ltd. | $1.62B | Small cap | −24.33% | Nov 12, 2026 |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% | Nov 3, 2026 |
| ARDT | Ardent Health, Inc. | $1.58B | Small cap | −11.64% | Nov 11, 2026 |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% | Nov 5, 2026 |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% | Nov 16, 2026 |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% | Nov 5, 2026 |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% | Oct 21, 2026 |
| 8086.T | Nipro Corporation | $1.57B | Small cap | +4.28% | Nov 10, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% | Oct 22, 2026 |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% | Nov 4, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% | Sep 14, 2026 |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% | Nov 12, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% | Sep 10, 2026 |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% | Nov 16, 2026 |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% | Nov 4, 2026 |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% | Nov 4, 2026 |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% | Oct 29, 2026 |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +19.48% | Nov 13, 2026 |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% | Nov 5, 2026 |
| NOLA-B.ST | Nolato AB (publ) | $1.50B | Small cap | −7.00% | Oct 29, 2026 |
| 6849.T | Nihon Kohden Corporation | $1.50B | Small cap | −7.26% | Nov 10, 2026 |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% | Nov 5, 2026 |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% | Nov 5, 2026 |
| RDC.DE | Redcare Pharmacy NV | $1.49B | Small cap | −23.82% | Oct 29, 2026 |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% | Sep 8, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% | Nov 5, 2026 |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% | Nov 12, 2026 |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% | Nov 20, 2026 |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% | Nov 5, 2026 |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% | Nov 4, 2026 |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% | Nov 4, 2026 |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% | Nov 4, 2026 |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% | Oct 29, 2026 |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% | Nov 12, 2026 |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% | Nov 11, 2026 |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% | Nov 12, 2026 |
| 4483.T | JMDC Inc. | $1.42B | Small cap | −17.21% | Nov 5, 2026 |
| GDS.PA | Ramsay Générale de Santé SA | $1.42B | Small cap | +9.50% | Oct 16, 2026 |
| IMTX | Immatics N.V. | $1.41B | Small cap | +74.63% | Nov 17, 2026 |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% | Nov 12, 2026 |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% | Nov 12, 2026 |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% | Nov 19, 2026 |
| 9627.T | Ain Holdings Inc. | $1.38B | Small cap | +2.85% | Sep 14, 2026 |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% | Oct 22, 2026 |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.35B | Small cap | +8.25% | Nov 10, 2026 |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% | Nov 5, 2026 |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +56.31% | Nov 4, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| AORT | Artivion, Inc. | $1.33B | Small cap | −37.81% | Nov 5, 2026 |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% | Nov 5, 2026 |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% | Nov 5, 2026 |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% | Nov 4, 2026 |
| CRON.TO | Cronos Group Inc. | $1.31B | Small cap | +39.83% | Nov 5, 2026 |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% | Nov 5, 2026 |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% | Oct 29, 2026 |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% | Nov 12, 2026 |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% | Sep 9, 2026 |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +2.77% | Nov 11, 2026 |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% | Nov 5, 2026 |
| GDRX | GoodRx Holdings, Inc. | $1.25B | Small cap | −18.89% | Nov 3, 2026 |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% | Nov 5, 2026 |
| 2175.T | SMS Co., Ltd. | $1.24B | Small cap | +54.71% | Oct 29, 2026 |
| ODTX | Odyssey Therapeutics, Inc. | $1.23B | Small cap | +56.03% | Nov 5, 2026 |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% | Nov 5, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% | Oct 22, 2026 |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% | Nov 3, 2026 |
| SNZ.AX | Summerset Group Holdings Limited | $1.22B | Small cap | −26.63% | Aug 27, 2026 |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.22B | Small cap | +34.65% | Nov 9, 2026 |
| 6523.T | PHC Holdings Corporation | $1.21B | Small cap | +58.42% | Nov 11, 2026 |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% | Nov 4, 2026 |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% | Sep 24, 2026 |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.18B | Small cap | −12.86% | Nov 13, 2026 |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% | Nov 4, 2026 |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% | Nov 3, 2026 |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% | Nov 5, 2026 |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −18.22% | Oct 28, 2026 |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% | Nov 11, 2026 |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.15B | Small cap | −35.42% | Nov 12, 2026 |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% | Nov 11, 2026 |
| IVA.PA | Inventiva S.A. | $1.14B | Small cap | −14.63% | Sep 25, 2026 |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.14B | Small cap | +24.49% | Nov 5, 2026 |
| IVA | Inventiva S.A. | $1.14B | Small cap | −7.84% | Sep 25, 2026 |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +8.36% | Nov 13, 2026 |
| TTALO.HE | Terveystalo Oyj | $1.14B | Small cap | −22.31% | Oct 21, 2026 |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% | Nov 3, 2026 |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% | Oct 28, 2026 |
| 7476.T | AS ONE Corporation | $1.11B | Small cap | +2.31% | Oct 30, 2026 |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% | Nov 12, 2026 |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.06B | Small cap | −1.28% | Oct 30, 2026 |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −2.60% | Nov 2, 2026 |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% | Nov 2, 2026 |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +104.42% | Nov 5, 2026 |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% | Nov 2, 2026 |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% | Nov 9, 2026 |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% | Nov 16, 2026 |
| GUBRA.CO | Gubra A/S | $1.02B | Small cap | +4.79% | Nov 6, 2026 |
| GXI.DE | Gerresheimer AG | $1.02B | Small cap | −39.73% | Aug 27, 2026 |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% | Nov 5, 2026 |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% | Nov 5, 2026 |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% | Nov 12, 2026 |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% | Nov 4, 2026 |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% | Nov 12, 2026 |
| 7730.T | Mani, Inc. | $994.58M | Small cap | +29.48% | Oct 15, 2026 |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% | Oct 29, 2026 |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% | Nov 5, 2026 |
| VETO.PA | Vetoquinol SA | $973.12M | Small cap | −6.37% | Sep 11, 2026 |
| BVS | Bioventus Inc. | $954.22M | Small cap | +86.52% | Nov 3, 2026 |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% | Nov 12, 2026 |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $949.35M | Small cap | +10.07% | Nov 10, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% | Nov 9, 2026 |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% | Nov 9, 2026 |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +53.00% | Oct 28, 2026 |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −27.78% | Nov 5, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% | Oct 22, 2026 |
| 3046.T | JINS HOLDINGS Inc. | $911.23M | Small cap | −22.48% | Oct 9, 2026 |
| ACRS | Aclaris Therapeutics, Inc. | $911.16M | Small cap | +240.11% | Nov 5, 2026 |
| DBV.PA | DBV Technologies S.A. | $901.25M | Small cap | +60.13% | Oct 28, 2026 |
| CBLL | CeriBell, Inc. | $899.97M | Small cap | +102.16% | Nov 3, 2026 |
| 4587.T | PeptiDream Inc. | $891.51M | Small cap | −27.31% | Nov 11, 2026 |
| SGP | SpyGlass Pharma, Inc. | $891.05M | Small cap | +0.91% | Nov 5, 2026 |
| TBPH | Theravance Biopharma, Inc. | $884.18M | Small cap | +23.41% | Nov 10, 2026 |
| SYNSAM.ST | Synsam AB (publ) | $873.75M | Small cap | +5.66% | Nov 12, 2026 |
| 7780.T | Menicon Co., Ltd. | $873.71M | Small cap | +54.36% | Nov 13, 2026 |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% | Oct 29, 2026 |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% | Oct 27, 2026 |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +144.54% | Nov 12, 2026 |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% | Nov 3, 2026 |
| INMD | InMode Ltd. | $864.89M | Small cap | −1.71% | Nov 4, 2026 |
| MCAP.ST | MedCap AB (publ) | $864.73M | Small cap | −10.28% | Oct 23, 2026 |
| SIBN | SI-BONE, Inc. | $861.71M | Small cap | +17.12% | Nov 9, 2026 |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% | Nov 10, 2026 |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% | Nov 5, 2026 |
| 4694.T | BML, Inc. | $851.50M | Small cap | +5.42% | Nov 6, 2026 |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% | Nov 5, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% | Oct 21, 2026 |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% | Sep 23, 2026 |
| SLN | Silence Therapeutics plc | $840.94M | Small cap | +160.19% | Nov 5, 2026 |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% | Nov 2, 2026 |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% | Sep 29, 2026 |
| APOTEA.ST | Apotea AB (publ) | $822.73M | Small cap | −26.38% | Nov 5, 2026 |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% | Nov 3, 2026 |
| WELL.TO | WELL Health Technologies Corp. | $807.72M | Small cap | −8.18% | Nov 5, 2026 |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% | Oct 22, 2026 |
| AURA | Aura Biosciences, Inc. | $801.64M | Small cap | +20.03% | Nov 12, 2026 |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% | Nov 12, 2026 |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% | Nov 12, 2026 |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% | Nov 17, 2026 |
| AHCO | AdaptHealth Corp. | $771.43M | Small cap | −38.44% | Nov 3, 2026 |
| NGNE | Neurogene Inc. | $768.64M | Small cap | +95.02% | Nov 12, 2026 |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% | Nov 12, 2026 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −0.43% | Nov 11, 2026 |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% | Nov 3, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% | Nov 5, 2026 |
| OCS | Oculis Holding AG | $720.20M | Small cap | −25.14% | Nov 5, 2026 |
| PHR | Phreesia, Inc. | $716.58M | Small cap | −63.74% | Sep 2, 2026 |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% | Oct 27, 2026 |
| DHT-UN.TO | DRI Healthcare Trust | $714.70M | Small cap | +27.29% | Nov 5, 2026 |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% | Oct 29, 2026 |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% | Nov 9, 2026 |
| GYRE | Gyre Therapeutics, Inc. | $705.12M | Small cap | −18.00% | Nov 5, 2026 |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% | Nov 5, 2026 |
| TECX | Tectonic Therapeutic, Inc. | $703.19M | Small cap | +35.43% | Nov 5, 2026 |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% | Nov 4, 2026 |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% | Nov 4, 2026 |
| EVT.DE | Evotec SE | $694.87M | Small cap | −45.75% | Nov 5, 2026 |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.02% | Oct 29, 2026 |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% | Nov 9, 2026 |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% | Nov 5, 2026 |
| GMRS | GMR Solutions Inc. | $692.56M | Small cap | −8.30% | Nov 16, 2026 |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% | Nov 5, 2026 |
| DHT-U.TO | DRI Healthcare Trust | $690.34M | Small cap | +27.68% | Nov 5, 2026 |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% | Nov 12, 2026 |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% | Nov 4, 2026 |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% | Nov 12, 2026 |
| CRMD | CorMedix Inc. | $653.95M | Small cap | −40.66% | Nov 16, 2026 |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% | Nov 6, 2026 |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% | Oct 1, 2026 |
| 4565.T | Nxera Pharma Co., Ltd. | $648.21M | Small cap | +22.68% | Oct 30, 2026 |
| MDXG | MiMedx Group, Inc. | $644.26M | Small cap | −38.35% | Oct 28, 2026 |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% | Nov 3, 2026 |
| TLRY.TO | Tilray Brands, Inc. | $640.36M | Small cap | +240.00% | Oct 8, 2026 |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% | Oct 29, 2026 |
| KIDS | OrthoPediatrics Corp. | $639.69M | Small cap | +11.10% | Oct 28, 2026 |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% | Oct 8, 2026 |
| CTEV | Claritev Corporation | $636.72M | Small cap | −47.71% | Nov 5, 2026 |
| AUTL | Autolus Therapeutics plc | $620.16M | Small cap | +48.41% | Nov 16, 2026 |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% | Nov 4, 2026 |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% | Nov 5, 2026 |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% | Nov 12, 2026 |
| CTKB | Cytek Biosciences, Inc. | $594.02M | Small cap | +11.74% | Nov 4, 2026 |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% | Nov 5, 2026 |
| EQS.PA | Equasens Société anonyme | $588.00M | Small cap | −25.98% | Sep 28, 2026 |
| WEAV | Weave Communications, Inc. | $584.79M | Small cap | −5.68% | Nov 5, 2026 |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% | Nov 4, 2026 |
| BWAY | BrainsWay Ltd. | $574.70M | Small cap | +87.42% | Nov 10, 2026 |
| ZURA | Zura Bio Limited | $574.02M | Small cap | +177.31% | Nov 12, 2026 |
| DCTH | Delcath Systems, Inc. | $569.06M | Small cap | +49.91% | Nov 3, 2026 |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% | Nov 10, 2026 |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% | Nov 3, 2026 |
| OVID | Ovid Therapeutics Inc. | $562.46M | Small cap | +128.57% | Nov 11, 2026 |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% | Nov 5, 2026 |
| CERS | Cerus Corporation | $552.18M | Small cap | +109.16% | Nov 5, 2026 |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +133.33% | Nov 11, 2026 |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% | Nov 16, 2026 |
| FLGT | Fulgent Genetics, Inc. | $545.08M | Small cap | −8.46% | Nov 6, 2026 |
| SRTA | Strata Critical Medical, Inc. | $541.42M | Small cap | +33.62% | Nov 9, 2026 |
| TCMD | Tactile Systems Technology, Inc. | $532.56M | Small cap | +78.78% | Nov 2, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% | Nov 11, 2026 |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% | Nov 5, 2026 |
| 4480.T | Medley, Inc. | $512.99M | Small cap | +9.22% | Nov 12, 2026 |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +79.19% | Nov 9, 2026 |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% | Oct 23, 2026 |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.75M | Small cap | −41.46% | Nov 5, 2026 |
| NPCE | NeuroPace, Inc. | $503.88M | Small cap | +65.32% | Nov 3, 2026 |
| EVMN | Evommune, Inc. | $500.47M | Small cap | −30.25% | Nov 16, 2026 |
| CLPT | ClearPoint Neuro, Inc. | $499.35M | Small cap | +53.85% | Nov 5, 2026 |
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −57.08% | Sep 14, 2026 |
| REG1V.HE | Revenio Group Oyj | $494.52M | Small cap | −38.54% | Sep 8, 2026 |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% | Nov 4, 2026 |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% | Nov 6, 2026 |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +40.72% | Nov 3, 2026 |
| WEED.TO | Canopy Growth Corporation | $489.98M | Small cap | −31.25% | Nov 6, 2026 |
| EDIT | Editas Medicine, Inc. | $488.38M | Small cap | +19.10% | Nov 9, 2026 |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | $487.17M | Small cap | +43.78% | Nov 3, 2026 |
| NRC | NRC Health | $487.06M | Small cap | +45.92% | Oct 26, 2026 |
| RLMD | Relmada Therapeutics, Inc. | $485.35M | Small cap | +579.10% | Nov 12, 2026 |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% | Sep 16, 2026 |
| PACB | Pacific Biosciences of California, Inc. | $484.90M | Small cap | +17.29% | Nov 5, 2026 |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% | Nov 9, 2026 |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% | Nov 10, 2026 |
| OCGN | Ocugen, Inc. | $478.15M | Small cap | +35.58% | Nov 5, 2026 |
| PRTA | Prothena Corporation plc | $474.87M | Small cap | +8.06% | Nov 5, 2026 |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% | Nov 5, 2026 |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% | Nov 5, 2026 |
| BIOA | BioAge Labs, Inc. | $451.63M | Small cap | +107.59% | Nov 5, 2026 |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% | Nov 5, 2026 |
| ARCT | Arcturus Therapeutics Holdings Inc. | $449.94M | Small cap | −8.44% | Nov 9, 2026 |
| BNTC | Benitec Biopharma Inc. | $442.48M | Small cap | +0.16% | Sep 22, 2026 |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +53.06% | Nov 11, 2026 |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% | Nov 5, 2026 |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% | Nov 5, 2026 |
| LRMR | Larimar Therapeutics, Inc. | $432.15M | Small cap | +6.92% | Nov 5, 2026 |
| EYPT | EyePoint, Inc. | $430.20M | Small cap | −57.85% | Nov 4, 2026 |
| FRX.TO | Fennec Pharmaceuticals Inc. | $429.52M | Small cap | +36.00% | Nov 12, 2026 |
| MASS | 908 Devices Inc. | $428.63M | Small cap | +64.60% | Nov 10, 2026 |
| FENC | Fennec Pharmaceuticals Inc. | $426.77M | Small cap | +34.62% | Nov 12, 2026 |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | $422.50M | Small cap | −19.86% | Nov 9, 2026 |
| LXEO | Lexeo Therapeutics, Inc. | $420.90M | Small cap | +3.30% | Nov 4, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.